Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03472664 · ClinicalTrials.gov registry record · NA

Brain Energy for Amyloid Transformation in Alzheimer's Disease Study

A NA study of Alzheimer Disease and Mild Cognitive Impairment, sponsored by Wake Forest University Health Sciences.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT03472664 is a NA study of Alzheimer Disease and Mild Cognitive Impairment that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 120 participants, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03472664, a NA study of Alzheimer Disease and Mild Cognitive Impairment, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

The Brain Energy for Amyloid Transformation in AD (Alzheimer's disease) or BEAT-AD study will compare the effects of a ketogenic low-carbohydrate diet and a low-fat diet in adults with mild cognitive impairment. The data collected will help determine whether diet interventions induce changes in cognitive function, cerebral blood flow, and levels of certain proteins and hormones in body fluids. The study will include volunteers who have mild cognitive impairment, who will be randomly assigned to receive either a ketogenic low-carbohydrate diet or a low-fat diet for 16-weeks, with follow-up assessment 8 weeks after diet completion. Study measures, clinic visits and phone sessions will occur at baseline and throughout the 24-week study. Participant will follow either a low-carbohydrate or low-fat diet that will be individually planned with help from a study dietitian. After completing the study diet for 16 weeks, participants will resume their normal diet. The final visits will occur at week 24 (8 weeks after the completing the diet). At the end of the 24-week study, participants will be given the opportunity to meet with the study dietitian for education and assistance with planning a healthy diet.

Interventions

  • OTHER low carbohydrate/high fat diet
  • OTHER low fat/high carbohydrate diet

Study Locations (1)

North Carolina

  • Wake Forest Baptist Medical Center - Winston-Salem

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2018-07-16
Est. Completion 2026-04
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT03472664

The ClinicalTrials.gov registry entry for NCT03472664 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (96% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which low carbohydrate/high fat diet is the first listed.

NCT03472664 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT03472664 about?

NCT03472664 is a clinical study titled "Brain Energy for Amyloid Transformation in Alzheimer's Disease Study". The Brain Energy for Amyloid Transformation in AD (Alzheimer's disease) or BEAT-AD study will compare the effects of a ketogenic low-carbohydrate diet and a low-fat diet in adults with mild cognitive impairment. The data collected will help determine whether diet interventions induce changes in cogn...

What is the current status of trial NCT03472664?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2018-07-16. Estimated completion is 2026-04.

What conditions does trial NCT03472664 study?

This clinical trial studies the following conditions: Alzheimer Disease, Mild Cognitive Impairment.

What interventions are being tested in trial NCT03472664?

The interventions under investigation include: low carbohydrate/high fat diet (OTHER), low fat/high carbohydrate diet (OTHER).

Who is sponsoring clinical trial NCT03472664?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03472664 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.